What Researchers Did
Researchers studied 89 patients with delayed brain damage after carbon monoxide poisoning, comparing standard care to standard care plus daily hyperbaric oxygen therapy, or standard care plus hyperbaric oxygen therapy and XingZhi-YiNao granules.
What They Found
Both hyperbaric oxygen therapy alone and combined with XingZhi-YiNao granules significantly improved neurological function, cognitive abilities, and reduced brain white matter injury compared to standard care (P < 0.05). The group receiving both hyperbaric oxygen and XingZhi-YiNao granules showed better results than the group receiving only hyperbaric oxygen therapy (P < 0.05).
What This Means for Canadian Patients
For Canadian patients experiencing delayed brain damage after carbon monoxide poisoning, this study suggests that hyperbaric oxygen therapy could help improve their cognitive and motor functions. While the study included an herbal granule not typically used in Canada, the findings support the potential benefits of HBOT for this specific condition.
Canadian Relevance
This study covers delayed encephalopathy after acute carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy. The study itself was not conducted in Canada, and no Canadian authors were identified.
Study Limitations
A limitation is the small size of the control group, and the study's primary finding of superior efficacy involved an herbal granule not commonly used in Canadian medical practice.